Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Science Track

Role of F-18 FDG PET/CT in restaging of patients with renal cell carcinoma: experience at a single tertiary care centre

ABHIRAM JOIS, Rajender Kumar, Apurva Sood, Anish Bhattacharya, Shrawan Singh and Bhagwant Mittal
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1566;
ABHIRAM JOIS
3Nuclear Medicine & PET POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND R CHANDIGARH India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajender Kumar
2Nuclear Medicine PGIMER Chandigarh India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Apurva Sood
4Nuclear Medicine & PET Postgraduate Institute of Medical Education & Research CHANDIGARH India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anish Bhattacharya
1Department of Nuclear Medicine Chandigarh India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shrawan Singh
4Nuclear Medicine & PET Postgraduate Institute of Medical Education & Research CHANDIGARH India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bhagwant Mittal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1566

Objectives In the present retrospective study, we evaluated the diagnostic performance of F-18 FDG PET/CT in the restaging of clear cell renal cell carcinoma (RCC) and its comparison with the conventional imaging.

Methods A total of 139 patients (male = 94, female = 45; median age = 53.3 years; range = 18-81 years) from June 2013 to November 2015, with histopathological proof of renal cell carcinoma were evaluated in this retrospective study. All the patients underwent whole-body F-18 FDG PET/CT for restaging of the disease after initial nephrectomy or after chemotherapy with clinical or radiological suspicion of recurrence. FDG PET/CT findings were evaluated by two experienced nuclear medicine physicians and any abnormal FDG uptake on PET images was correlated with lesion on CECT and taken as positive. For the validation of the imaging results, histopathological examinations, clinical or imaging follow up were taken as reference standard. Conventional anatomical images (USG / CT or MR scans) were also evaluated for comparison (wherever available).

Results Of the 139 patients, 115 patients had clear cell carcinoma on histopathology, 8 chromophobe, 10 papillary carcinoma and 6 sarcomatoid carcinoma. FDG PET/CT revealed positive findings in 72 patients and negative in 67 patients. Out of 72 PET positive patients, 29 had regional disease (renal bed or retroperitoneal disease), regional and distant metastases in 18 patients and only distant metastases in 25 patients. Sixty-eight patients were true positive (TP), 4 patients false positive (FP), 64 patients were true negative (TN), and 3 patients were false negative (FN). FDG PET/ CT had shown sensitivity, specificity, positive predictive value, and negative predictive values of 95.7%, 94.1%, 94.4%, and 95.5% respectively. Conventional imaging (CECT/MRI or USG) were available in 39 patients (TP -20, FP-14, FN-2 and TN -3) and revealed sensitivity, specificity, positive predictive value, and negative predictive values of 90.9%, 16.2%, 58.8%, and 60.0 % respectively.

Conclusions Our results indicate that F-18 FDG PET have very high specificity, PPV and NPV as compared to conventional imaging. FDG PET/CT had shown an excellent diagnostic performance and it performed better than conventional imaging in restaging of renal cell carcinoma patients.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of F-18 FDG PET/CT in restaging of patients with renal cell carcinoma: experience at a single tertiary care centre
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Role of F-18 FDG PET/CT in restaging of patients with renal cell carcinoma: experience at a single tertiary care centre
ABHIRAM JOIS, Rajender Kumar, Apurva Sood, Anish Bhattacharya, Shrawan Singh, Bhagwant Mittal
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1566;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of F-18 FDG PET/CT in restaging of patients with renal cell carcinoma: experience at a single tertiary care centre
ABHIRAM JOIS, Rajender Kumar, Apurva Sood, Anish Bhattacharya, Shrawan Singh, Bhagwant Mittal
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1566;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Science Track

  • Clinical management and outcomes in differentiated thyroid cancer patients with positive postoperative-stimulated thyroglobulin antibody and undetectable postoperative-stimulated thyroglobulin at initial 131I ablation after total thyroidectomy
  • Clinical value of 68Ga-DOTATATE PET/CT in the evaluation of recurrent medullary thyroid cancer patients.
  • The diagnostic performance and added value of 18F-NaF PET/CT in the detection of bone metastases in patients with nasopharyngeal carcinoma
Show more Oncology, Clinical Science Track

MTA I: Prostate/GU Posters

  • Radiographic and laboratory assessment of bone metastases in castration-resistant prostate cancer patients undergoing Radium-223 dichloride therapy
  • Ga-68-PSMA11 PET/CT vs. multi-parametric MRI for primary prostate cancer T-staging
  • Initial experience with 11C-acetate PET/CT in management of recurrent prostate cancer under an Expanded Access IND.
Show more MTA I: Prostate/GU Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire